Gazyva
Gazyva
GAZYVA (obinutuzumab) is a prescription medicine that targets the CD20-directed cytolytic antibody indicated for the treatment of adult patients with active lupus nephritis (LN) who are receiving standard therapy.
Administration Information
GAZYVA is administered as an intravenous infusion with 4 infusions in the first year then only 2 infusions a year going forward. Patients will receive 1000mg doses in Weeks 0 and 2 then again in Weeks 24 and 26. Six months later they will receive 1 dose every 6 months.
Potential Side Effects
The most common side effects that occurred in patients who received GAZYVA plus standard therapy for lupus nephritis were upper respiratory tract infection, COVID-19, urinary tract infection, bronchitis, pneumonia, infusion-related reactions, and low white blood cell count (also known as neutropenia).
Speak to your doctor about side effects or if you have any questions. Click here to review safety information and side effects when taking GAZYVA.
Helpful Resources
Patient Financial Assistance
How Gazyva Works
Understanding Lupus Nephritis
Sage Infusion Treatment Tips - Lupus
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Patient Consent Form
HIPAA Privacy Authorization Form
Notice of Privacy Practices
Patient Rights and Responsibilities
Appointment Lateness and Cancelation
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP
Central Florida
Southwest Florida
Tampa Bay East
Tampa Bay West